Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: HAZEL Campylobacter

PROVIDER: PRJNA1026168 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26328600_1.fastq.gz	Fastqsanger.gz
	SRR26328600_2.fastq.gz	Fastqsanger.gz
	SRR26328700_1.fastq.gz	Fastqsanger.gz
	SRR26328700_2.fastq.gz	Fastqsanger.gz
	SRR26328601_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 356

Similar Datasets

dhCorAvel

Project description:Corylus avellana (hazel)

| PRJEB81049 | ENA

mMusAve

Project description:Muscardinus avellanarius (hazel dormouse)

| PRJEB64959 | ENA

icApoCory

Project description:Apoderus coryli (hazel leaf-roller)

| PRJEB45119 | ENA

Affymetrix SNP array data for chicken responses to glycoconjugate vaccination against Campylobacter jejuni

Project description:Campylobacter jejuni is a common cause of diarrheal disease worldwide. Human infection typically occurs through the ingestion of contaminated poultry products. We previously demonstrated that an attenuated Escherichia coli live vaccine strain expressing the C. jejuni N-glycan on its surface reduces the Campylobacter load in more than 50% of vaccinated leghorn and broiler birds to undetectable levels (responder birds), whereas the remainder of the animals were still colonized (non-responders). To understand the underlying mechanism, we conducted 3 larger scale vaccination and challenge studies using 135 broiler birds and found a similar responder/non responder effect. The submitted data were used for a genome-wide association study of the chicken responses to glycoconjugate vaccination against Campylobacter jejuni.

2021-11-01 | GSE181619 | GEO

Transcriptional analysis of C. jejuni response to FQ treatment

Project description:Fluoroquinolones (FQs) are one class of commonly used antimicrobials in clinical therapy of diseases caused by Campylobacter and other foodborne pathogens. The molecular mechanisms underlying the response of Campylobacter to FQ treatment is of interest because unlike other enteric bacteria, Campylobacter lacks many genes encoding components of DNA repair systems and SOS response. To understand how Campylobacter survive antibiotic treatment, DNA microarray was used to compare the gene expression profiles of C. jejuni 11168 in the presence and absence of ciprofloxacin. Our analysis identified 45 genes that showed ≥1.5-fold (p<0.05) changes in expression in the presence of ciprofloxacin. The up-regulated genes (13) are involved in cell membrane biosynthesis and DNA repair or have unknown functions, while the majority of the down-regulated genes (32) are involved in cellular process and energy metabolism. These findings suggest that C. jejuni modulates membrane biosynthesis, increases spontaneous mutation rates, and decreases metabolism in response to fluoroquinolone treatment. Keywords: 0.06 µg/ml (0.5X MIC) or 1.2 µg/ml (10X MIC) ciprofloxacin treated campylobacter VS. untreated campylobacter, the bacterial cells were treated for 0.5 hour

2008-06-09 | GSE10471 | GEO

Project description:Microbe diversity analysis of mycorrhizal fungi-rich hazel orchard and mycorrhizal fungi-deficient hazel orchard.

| PRJNA863462 | ENA

Project description:Raw data of hazel (Corylus spp.)

| PRJNA591492 | ENA

LFQ of Campylobacter fetus subsp. fetus strains

Project description:Comparsion of proteomes of Campylobacter fetus subsp. fetus to compare protein level via iBAQ analysis, expression (by LFQ) and coverage between Campylobacter fetus subsp. fetus strain82-40 vs Campylobacter fetus subsp. fetus strain ATCC 27374

2020-05-25 | PXD014538 | Pride

Diarrhoeal mechanisms of the Campylobacter jejuni enteritis

Project description:Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. This study aims at the characterisation of pathomechanisms and signalling in Campylobacter-induced diarrhoea in the human mucosa. During routine colonoscopy, biopsies were taken from patients suffering from campylobacteriosis. RNA-seq of colon biopsies was performed to describe Campylobacter jejuni-mediated effects. Mucosal mRNA profiles of acutely infected patients and healthy controls were generated by deep sequencing using Illumina HiSeq 2500. This data provide the basis for subsequent upstream regulator analysis.

2017-10-10 | GSE88710 | GEO

Transcriptional profile in macrolide susceptible and resistant Campylobacter jejuni

Project description:Campylobacter jejuni is a major zoonotic pathogen transmitted to humans via the food chain. C. jejuni is prevalent in chickens, a natural reservoir for this pathogenic organism. Due to the importance of macrolide antibiotics in clinical therapy of human campylobacteriosis, development of macrolide resistance in Campylobacter has become a concern for public health.To facilitate understanding the molecular basis associated with the fitness difference between Erys and Eryr Campylobacter, we compared the transcriptomes between ATCC 700819 and its isogenic Eryr transformant T.L.101 using DNA microarray.

2011-11-02 | GSE33330 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data